Novo Nordisk CEO to testify before Senate on weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on August 10, 2022. Christopher Goodney…
pharmaceutical products
Why Eli Lilly and Palo Alto Networks are keeping up with their competitors
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
FTC sues drug brokers for allegedly inflating insulin prices
Federal Trade Commission (FTC) Chair Lina Khan testifies before the House Appropriations Subcommittee in the Rayburn House Office Building on…
Novartis CEO says it won't join weight-loss drug frenzy
The CEO of Novartis The Swiss pharmaceutical giant has no intention of getting into the “frenzy” of weight loss drugs,…
Pfizer's drug for cancer cachexia shows positive results in mid-phase trials
PfizerPfizer's experimental drug for a common, potentially fatal disease that causes cancer patients to lose appetite and weight showed positive…
Florida advises against the use of mRNA vaccines against Covid in older adults
As the Covid wave continues in Florida, Gov. Ron DeSantis' administration is again advising against mRNA vaccines — this time…
Noom to offer GLP-1 drug through new weight loss program
Digital health company Noom announced Thursday that it will offer a compounded GLP-1 drug as part of a new weight-loss…
$1 billion in cost cuts and 10 planned product launches
Moderna headquarters, exterior view, Cambridge, Massachusetts, USA. Plexi Images | GHI | UCG | Universal Images Group | Getty Images…
Eli Lilly to increase production of weight loss, diabetes and Alzheimer's drugs
A sign with the company logo is displayed outside Eli Lilly headquarters in Indianapolis, Indiana, March 17, 2024. Scott Olson…
AstraZeneca shares fall 5% on disappointing lung cancer drug trial
AstraZeneca Shares fell more than 5% on Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical…